{
    "root": "b1e7ffe5-7d5f-4e02-a9c9-3d9ad3fac23e",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Clonidine Hydrochloride",
    "value": "20250307",
    "ingredients": [
        {
            "name": "Clonidine Hydrochloride",
            "code": "W76I6XXF06"
        },
        {
            "name": "silicon dioxide",
            "code": "ETJ7Z6XBU4"
        },
        {
            "name": "hypromellose, unspecified",
            "code": "3NXW29V3WO"
        },
        {
            "name": "lactose monohydrate",
            "code": "EWQ57Q8I5X"
        },
        {
            "name": "magnesium stearate",
            "code": "70097M6I30"
        },
        {
            "name": "starch, corn",
            "code": "O8232NY3SJ"
        },
        {
            "name": "sodium lauryl sulfate",
            "code": "368GB5141J"
        }
    ],
    "indications": "clonidine hydrochloride extended-release tablets indicated treatment attention deficit hyperactivity disorder ( adhd ) monotherapy adjunctive therapy stimulant medications [ ( 14 ) ] .",
    "contraindications": "start one 0.1 mg tablet bedtime one week . increase daily increments 0.1 mg/day weekly intervals desired response achieved . take twice day , either equal higher split given bedtime , depicted ( 2.2 ) total daily dose morning dose bedtime dose 0.1 mg/day 0.1 mg 0.2 mg/day 0.1 mg 0.1 mg 0.3 mg/day 0.1 mg 0.2 mg 0.4 mg/day 0.2 mg 0.2 mg crush , chew break tablet swallowing . ( 2.1 ) substitute clonidine products mg-per-mg basis , differing pharmacokinetic profiles . ( 2.1 ) discontinuing , taper dose decrements 0.1 mg every 3 7 days avoid rebound hypertension . ( 2.3 )",
    "warningsAndPrecautions": "clonidine hydrochloride extended-release tablet 0.1 mg white off-white round , biconvex tablets debossing : `` u `` one side `` 77 `` side supplied follows . bottles 60 tablets child-resistant closure , ndc 70069-044-01 store 20° 25°c ( 68° 77°f ) ; excursions permitted 15° 30°c ( 59° 86°f ) [ usp controlled room temperature ] . dispense tight container defined usp . keep clonidine hydrochloride extended-release tablets medicines reach children .",
    "adverseReactions": "clonidine hydrochloride extended-release tablets contraindicated patients history hypersensitivity reaction clonidine . included generalized rash , urticaria , angioedema [ ( 6 ) ] .",
    "indications_original": "Clonidine hydrochloride extended-release tablets are indicated for the treatment of attention deficit hyperactivity disorder (ADHD) as monotherapy and as adjunctive therapy to stimulant medications [see Clinical Studies (14)].",
    "contraindications_original": "Start with one 0.1 mg tablet at bedtime for one week. Increase daily dosage in increments of 0.1 mg/day at weekly intervals until the desired response is achieved. Take twice a day, with either an equal or higher split dosage being given at bedtime, as depicted below ( 2.2 ) Total Daily Dose Morning Dose Bedtime Dose 0.1 mg/day 0.1 mg 0.2 mg/day 0.1 mg 0.1 mg 0.3 mg/day 0.1 mg 0.2 mg 0.4 mg/day 0.2 mg 0.2 mg Do      not crush, chew or break tablet before swallowing. ( 2.1 ) Do      not substitute for other clonidine products on a mg-per-mg basis, because      of differing pharmacokinetic profiles. ( 2.1 ) When      discontinuing, taper the dose in decrements of no more than 0.1 mg every 3      to 7 days to avoid rebound hypertension. ( 2.3 )",
    "warningsAndPrecautions_original": "Clonidine hydrochloride extended-release tablet 0.1 mg is a white to off-white round, biconvex tablets with debossing: \"U\" on one side and \"77\" on the other side and supplied as follows.\n                  Bottles of 60 tablets with child-resistant closure, NDC 70069-044-01 \n                  Store at 20° to 25°C (68° to 77°F); excursions permitted to 15° to 30°C (59° to 86°F) [See USP Controlled Room Temperature].\n                  Dispense in a tight container as defined in the USP.\n                  Keep clonidine hydrochloride extended-release tablets and all medicines out of the reach of children.",
    "adverseReactions_original": "Clonidine hydrochloride extended-release tablets are contraindicated in patients with a history of a hypersensitivity reaction to clonidine. Reactions have included generalized rash, urticaria, and angioedema [see Adverse Reactions (6)]."
}